UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | V | W
Number of items: 52.

A

ALLEN, DG; BAAK, J; BELPOMME, D; BEREK, JS; BERTELSEN, K; HUININK, WWT; VANDERBURG, MEL; ... DEVRIES, EGE; + view all (1993) ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS. ANN ONCOL , 4 83 - 88.

Abbasi, AM; Chester, KA; Talbot, IC; Macpherson, AS; Boxer, G; Forbes, A; Malcolm, ADB; (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epitheial-cells. European Journal of Cancer , 29A (14) pp. 1995-2002.

B

BEGENT, RHJ; CHESTER, KA; CONNORS, T; CROWTHER, D; FOX, B; GRIFFITHS, E; HINCE, TA; ... ZWIERZINA, H; + view all (1993) CANCER-RESEARCH CAMPAIGN OPERATION MANUAL FOR CONTROL RECOMMENDATIONS FOR PRODUCTS DERIVED FROM RECOMBINANT-DNA TECHNOLOGY PREPARED FOR INVESTIGATIONAL ADMINISTRATION TO PATIENTS WITH CANCER IN PHASE-I TRIALS. EUR J CANCER , 29A (13) 1907 - 1910.

Begent, RHJ; Chester, KA; Connors, T; Crowther, D; Fox, B; Griffiths, E; Hince, TA; ... Zwierzina, H; + view all (1993) Cancer research campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials. European Journal of Cancer , 29 (13) pp. 1907-1910. 10.1016/0959-8049(93)90549-U.

Beyaert, R; Vanhaesebroeck, B; Heyninck, K; Boone, E; De Valck, D; Schulze-Osthoff, K; Haegeman, G; ... Fiers, W; + view all (1993) Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine. Cancer Res , 53 (11) pp. 2623-2630.

C

CALVERT, AH; LIND, MJ; MILLWARD, MM; CANTWELL, BMJ; GUMBRELL, L; PROCTOR, M; SIMMONS, D; ... NEWELL, D; + view all (1993) LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS. CANCER TREAT REV , 19 27 - 33.

CALVERT, H; JUDSON, I; VANDERVIJGH, WJF; (1993) PLATINUM COMPLEXES IN CANCER MEDICINE - PHARMACOKINETICS AND PHARMACODYNAMICS IN RELATION TO TOXICITY AND THERAPEUTIC ACTIVITY. CANCER SURV , 17 189 - 217.

CAYEUX, SJ; BEVERLEY, PCL; SCHULZ, R; DORKEN, B; (1993) ELEVATED PLASMA PROSTAGLANDIN E(2) LEVELS FOUND IN 14 PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW OR STEM-CELL TRANSPLANTATION. BONE MARROW TRANSPL , 12 (6) 603 - 608.

CHIANELLI, M; SIGNORE, A; HICKS, R; TESTI, R; NEGRI, M; BEVERLEY, PCL; (1993) A SIMPLE METHOD FOR THE EVALUATION OF RECEPTOR-BINDING CAPACITY OF MODIFIED CYTOKINES. J IMMUNOL METHODS , 166 (2) 177 - 182.

Cooper, DP; Lee, SM; Margison, GP; O'Connor, PJ; Thatcher, N; Crowther, D; (1993) Relationship between 06-alkylguanine-DNA-alkyltransferase activity and 06-methyldeoxyguanosine formation after treatment with methylating agents in patients with malignant melanoma. In: (pp. 36-).

D

Davis, CL; Rohatiner, AZS; Lim, J; Whelan, JS; Amess, J; Love, S; Stead, E; (1993) The management of recurrent acute myelogenous leukaemia at a single center over a fifteen year period. British Journal of Haematology , 83 pp. 404-411.

Dhaliwal, HS; Rohatiner, AZS; Gregory, W; Richards, MA; Johnson, PWM; Whelan, JS; Gallager, CJ; ... Lister, TA; + view all (1993) Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. British Journal of Cancer , 68 pp. 767-774.

E

Evans, TR; Stein, RC; Pepper, JR; Gazet, JC; Ford, HT; Coombes, RC; (1993) A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer. Eur J Cancer , 29A (3) pp. 316-319.

F

FISHER, TC; MILNER, AE; GREGORY, CD; JACKMAN, AL; AHERNE, GW; HARTLEY, JA; DIVE, C; (1993) BCL-2 MODULATION OF APOPTOSIS INDUCED BY ANTICANCER DRUGS - RESISTANCE TO THYMIDYLATE STRESS IS INDEPENDENT OF CLASSICAL RESISTANCE PATHWAYS. CANCER RES , 53 (14) 3321 - 3326.

FISHWICK, D; LOUGHNEY, E; LIND, M; CALVERT, H; CORRIS, PA; GIBSON, GJ; (1993) COMPARISON OF MYELOTOXICITY RELATING TO 2 CHEMOTHERAPY REGIMENS FOR SMALL-CELL LUNG-CANCER (SCLC). AM REV RESPIR DIS , 147 (4) A749 - A749.

FOSTER, BJ; NEWELL, DR; CARMICHAEL, J; HARRIS, AL; GUMBRELL, LA; JONES, M; GOODARD, PM; (1993) PRECLINICAL, PHASE-I AND PHARMACOKINETIC STUDIES WITH THE DIMETHYL PHENYLTRIAZENE-CB10-277. BRIT J CANCER , 67 (2) 362 - 368.

FOSTER, BJ; NEWELL, DR; GUMBRELL, LA; JENNS, KE; CALVERT, AH; (1993) PHASE-I TRIAL WITH PHARMACOKINETICS OF CB10-277 GIVEN BY 24 HOURS CONTINUOUS INFUSION. BRIT J CANCER , 67 (2) 369 - 373.

G

GARBIRAS, BJ; WYATT, MD; WRIGHT, SR; LEE, M; FORROW, S; HARTLEY, JA; (1993) DNA-BINDING STUDIES OF N-TO-C OLIGOMETHYLENE-LINKED ANALOGS OF DISTAMYCIN-A. ABSTR PAP AM CHEM S , 206 120 - MEDI.

Gerard, B; Aamdal, S; Lee, SM; Leyvraz, S; Lucas, C; D'Incalci, M; Bizzari, JP; (1993) Activity and unexpected lung toxicity of the sequential administration of two alkylating agents-dacarbazine and fotemustine-in patients with melanoma. European Journal of Cancer , 29A (5) pp. 711-719.

Grooten, J; Goossens, V; Vanhaesebroeck, B; Fiers, W; (1993) Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine , 5 (6) pp. 546-555.

H

HARTLEY, JA; SOUHAMI, RL; BERARDINI, MD; (1993) ELECTROPHORETIC AND CHROMATOGRAPHIC-SEPARATION METHODS USED TO REVEAL INTERSTRAND CROSS-LINKING OF NUCLEIC-ACIDS. J CHROMATOGR-BIOMED , 618 (1-2) 277 - 288.

HARTLEY, JM; NICHOLSON, PW; ALLEN, R; LAMOND, P; HARLAND, SJ; SOUHAMI, RL; (1993) PHARMACOKINETICS OF 10-ETHYL-10-DEAZA-AMINOPTERIN, EDATREXATE, GIVEN WEEKLY FOR NON-SMALL-CELL LUNG-CANCER. CANCER CHEMOTH PHARM , 31 (4) 328 - 332.

HOCHHAUSER, D; HARRIS, AL; (1993) THE ROLE OF TOPOISOMERASE-II-ALPHA AND TOPOISOMERASE-II-BETA IN DRUG-RESISTANCE. CANCER TREAT REV , 19 (2) 181 - 194.

Harland, SJ; Cook, PA; Fossa, SD; Horwich, A; Parkinson, MC; Roberts, JT; Stenning, SP; (1993) Risk factors for carcinoma-in-situ of the contralateral testis in patients with testicular cancer; an interim report. European Urology , 23 pp. 202-206.

Hochhauser, D; Harris, AL; (1993) The role of topoisomerase II alpha and beta in drug resistance. Cancer Treat Rev , 19 (2) pp. 181-194.

J

JACKMAN, AL; BISSET, GMF; JODRELL, DI; GIBSON, W; KIMBELL, R; BAVETSIAS, V; CALVERT, AH; ... BOYLE, FT; + view all (1993) GAMMA-LINKED DIPEPTIDE ANALOGS OF 2-DESAMINO-2-METHYL-N-10-PROPARGYL-5,8-DIDEAZAFOLATE AS ANTITUMOR AGENTS. CHEMISTRY AND BIOLOGY OF PTERIDINES AND FOLATES , 338 579 - 584.

Johnson, PWM; Whelan, JS; Longhurst, S; Stepniewska, K; Matthews, J; Amess, J; Norton, A; ... Lister, TA; + view all (1993) B-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas. British Journal of Cancer , 67 pp. 792-797.

K

KELLY, K; PRITCHARD, J; GORDON, I; BEVERLEY, PCL; CHU, AC; (1993) CD1 ANTIBODY IMMUNOLOCALIZATION IN LANGERHANS CELL HISTIOCYTOSIS. LANCET , 342 (8867) 367 - 368.

L

LEE, M; RHODES, AL; WYATT, MD; DINCALCI, M; FORROW, S; HARTLEY, JA; (1993) INVITRO CYTOTOXICITY OF GC SEQUENCE DIRECTED ALKYLATING-AGENTS RELATED TO DISTAMYCIN. J MED CHEM , 36 (7) 863 - 870.

LEE, M; RHODES, AL; WYATT, MD; FORROW, S; HARTLEY, JA; (1993) DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF DNA-SEQUENCE AND MINOR-GROOVE SELECTIVE ALKYLATING-AGENTS. ANTI-CANCER DRUG DESIGN , 8 (3) pp. 173-192.

LEE, M; RHODES, AL; WYATT, MD; FORROW, S; HARTLEY, JA; (1993) GC-BASE SEQUENCE RECOGNITION BY OLIGO(IMIDAZOLECARBOXAMIDE) AND C-TERMINUS-MODIFIED ANALOGS OF DISTAMYCIN DEDUCED FROM CIRCULAR-DICHROISM, PROTON NUCLEAR-MAGNETIC-RESONANCE, AND METHIDIUMPROPYLETHYLENEDIAMINETETRAACETATE-IRON(II) FOOTPRINTING STUDIES. BIOCHEMISTRY , 32 (16) pp. 4237-4245. 10.1021/bi00067a011.

Lee, SM; Harris, M; Rennison, J; Crowther, D; McGown, A; Bromley, M; Elder, RH; ... Margison, GP; + view all (1993) In situ expression of 06-methylguanine-DNA methyltransferase in ovarian and Hodgkin's tumours. In: (Proceedings) BACR/ACP/BOA Annual Meeting, Sheffield.. (pp. 80-). British Journal of Cancer

Lee, SM; Harris, M; Rennison, J; McGown, A; Bromley, M; Elder, RH; Rafferty, JA; ... Margison, GP; + view all (1993) Expression of 06-alkylguanine-DNA alkyltransferase in situ in ovarian and Hodgkin's Tumours. European Journal of Cancer , 29A (9) pp. 1306-1312.

Lee, SM; Margison, GP; Woodcock, AA; Thatcher, N; (1993) Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. British Journal of Cancer , 67 (6) pp. 1356-1360.

Lee, SM; O'Connor, P; Thatcher, N; Crowther, D; Margison, GP; Cooper, D; (1993) Formation and loss of 06-methyldeoxyguanosine (06-MedG) in peripheral leukocytes of patients receiving dacarbazine (DTIC) or CB 10-277. In: (Proceedings) 1993 AACR Annual Meeting/84th Annual Meeting, Orlando, FL.. (pp. 355-). Proc Am Assoc Cancer Res

Lee, SM; Thatcher, N; Crowther, D; Margison, GP; (1993) Inactivation of 06-alkylguanine-DNA alkyltransferase in human blood mononuclear cells by temozolomide. In: (Proceedings) Association of Cancer Physicians 9th Annual Meeting, Birmingham, UK.. (pp. 60-). British Journal of Cancer

Lee, SM; Thatcher, N; Dougal, M; Margison, ; GP, ; (1993) Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on 06-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells. British Journal of Cancer , 67 (2) pp. 216-221.

M

MacCallum, PK; Davis, CL; Rohatiner, AZS; Lim, J; Gupta, RK; Whelan, JS; Price, CGA; ... Lister, TA; + view all (1993) Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukaemia at first recurrence. Leukemia , 7 pp. 1496-1499.

N

NEWELL, DR; PEARSON, ADJ; BALMANNO, K; PRICE, L; WYLLIE, RA; KEIR, M; CALVERT, AH; ... STEVENS, MCG; + view all (1993) CARBOPLATIN PHARMACOKINETICS IN CHILDREN - THE DEVELOPMENT OF A PEDIATRIC DOSING FORMULA. J CLIN ONCOL , 11 (12) 2314 - 2323.

Newell, DR; Pearson, AD; Balmanno, K; Price, L; Wyllie, RA; Keir, M; Calvert, AH; ... Stevens, MC; + view all (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol , 11 (12) pp. 2314-2323. 10.1200/JCO.1993.11.12.2314.

O

O'Connor, PJ; Lee, SM; Cooper, DP; Thatcher, N; Rafferty, J; Fan, CY; Zaidi, SNHMGP; (1993) Heterogeneity in the mechanisms of resistance to chemotherapy related to DNA damage and repair. In: D'Incalci, M and Mantovani, A and Garattini, S, (eds.) Heterogeneity of Cancer Cells. (pp. 89-103). Raven Press: New York.

P

PRETI, C; TROUTMAN, MV; LEE, M; FORROW, S; HARTLEY, JA; (1993) DESIGN, SYNTHESIS, AND DNA-BINDING PROPERTIES OF C-TERMINUS TRUNCATED AND IMIDAZOLE-CONTAINING ANALOGS OF DISTAMYCIN. ABSTR PAP AM CHEM S , 206 121 - MEDI.

PUVVADA, MS; HARTLEY, JA; JENKINS, TC; THURSTON, DE; (1993) A quantitative assay to measure the relative dna-binding affinity of pyrrolo[2,1-c][1,4]benzodiazepine (pbd) antitumor antibiotics based on the inhibition of restriction-endonuclease bamhi. Nucleic Acids Research , 21 (16) 3671 - 3675. 10.1093/nar/21.16.3671. Green open access
file

Perren, TJ; Wiltshaw, E; Harper, P; Slevin, M; Stein, R; Tan, S; Gore, M; ... Blake, PR; + view all (1993) A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group. Br J Cancer , 68 (6) pp. 1190-1194.

Pigaditou, A; Rohatiner, AZ; Whelan, JS; Johnson, PW; Ganjoo, RK; Rossi, A; Norton, AJ; ... Lister, TA; + view all (1993) Fludarabine in low-grade lymphoma. Seminars in Oncology , 20 (5) pp. 24-7.

R

Rohatiner, AZS; Bassan, R; Battista, R; Whelan, JS; Johnson, PWM; Amess, JAL; Arnott, SJ; ... Lister, TA; + view all (1993) Myeloablative therapy with autologous bone marrow transplantation (ABMT) as consolidation of first remission in younger patients with acute myelogenous leukaemia (AML). In:

Rohatiner, AZS; Johnson, PWM; Mahmoud, M; Arnott, SJ; Amess, JAL; Norton, AJ; Adams, K; ... Lister, TA; + view all (1993) Myeloablative therapy with autologous bone marrow transplantation (ABMT) in low grade lymphoma. In:

V

Vanhaesebroeck, B; Reed, JC; De Valck, D; Grooten, J; Miyashita, T; Tanaka, S; Beyaert, R; ... Fiers, W; + view all (1993) Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene , 8 (4) pp. 1075-1081.

W

Whelan, J; (1993) Hypercalcaemia and adamantinoma (letter). Sarcoma , 3 197-. Gold open access

Whelan, JS; Ganjoo, R; Johnson, PWM; Rohatiner, AZS; Lister, TA; (1993) Treatment of low grade non-Hodgkin's lymphomas with Fludarabine. Leukemia and Lymphoma , 10 (S1) pp. 35-37.

Whelan, JS; Phear, G; Yamauchi, M; Meuth, M; (1993) Clustered base substitutions in CTP synthetase conferring drug resistance in CHO cells. Nature Genetics , 3 pp. 317-321.

Whelan, JS; Radford, JA; Stansfeld, AG; Harris, M; Johnson, PWM; Matthews, J; Deakin, D; ... Lister, TA; + view all (1993) Intensive combination chemotherapy for diffuse low grade non-Hodgkin's lymphomas of B- and T-cell lineage. In:

This list was generated on Sun Aug 20 02:20:46 2017 BST.